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characteristic erosion, found especially in PIP, is the so-called “saw tooth”
appearance.
Results: Although the diagnosis of EOA is based on radiographic ero-
sions, some clinical features may lead to a suspicion of EOA. According
to the deﬁnition of “inﬂammatory OA”, abrupt onset of pain, swelling,
redness, warmth and limited function of IP joints are common. Sometimes
the same features may be observed in non-EOA cases, but usually at the
disease onset, during the ﬁrst year. Characteristic of EOA is the throbbing
paresthesias of the ﬁngertips. EOA may lead to joint deformities, some
indistinguishable from those of non-EOA, such as lateral subluxations
and Heberden’s and Bouchard’s nodes, while others are seen almost
exclusively in EOA, such as instability and ankylosis of DIP and PIP and,
rarely, opera-glass deformity.
Concerning laboratory investigations, ultrasensitive CRP has been pro-
posed as marker of the disease activity. Some OA markers, such as the
CTX I, were found to be increased in the serum and urine in EOA in
comparison with nodal non-EOA. In another recent study, serum levels
of myeloperoxydase (MPO) and, at lesser extent, Coll2−1NO2, were
elevated in EOA in comparison with non-EOA.
Pattrick et al observed an increased frequency of the HLA-A1B8 and
MZ a1-antitrypsin phenotypes in patients with nodal OA. Among these,
patients with EOA had an increased frequency of the MZ a1-antitrypsin
phenotype (30 versus 9%). We found that HLA DRB1*011 was associ-
ated with EOA, in comparison with non-EOA and reference populations.
Stern et al reported an association between EOA and a genomic region
containing the interleukin-1b (Il-1b) 5810 single nucleotide polymorphism,
thus supporting a potential role for Il-1 in the pathogenesis of this severe
phenotype of hand OA.
In comparison with nodal OA, clinical aspects of EOA may sometimes
be indistinguishable, although EOA is characterized by more frequent
inﬂammatory episodes involving several joints simultaneously and may
persist for many years, while nodal generalized OA exhibits its ﬂares
mainly at onset of the involvement of each joint, in a ‘stuttering’ onset
polyarthropathy of DIPs and PIPs which resembles a ‘monoarthritis
multiplex’. Furthermore, instability and ankylosis of IPs are seen almost
exclusively in EOA.
Conclusions: According to the recent EULAR recommendations for the
diagnosis of hand OA, EOA may be considered “as subset of hand OA,
characterized by radiographic erosions targeting IP joints which may
progress to marked bone and cartilage attrition, instability and bony
ankylosis. Typically it has an abrupt onset; marked pain and functional
impairment; inﬂammatory symptoms and signs (stiffness, soft tissue
swelling, erythema, paraesthesiae); mildly elevated CRP; and a worse
outcome than non-EOA”.
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Purpose: The majority of patients suffering from osteoarthritis (OA)
desire effective and safe pain relief. Despite the growing number of
OA patients worldwide and the pressing need for efﬁcacious analgesics,
surprisingly little is known about the source and mechanisms of OA pain
(for review see McDougall, 2006. Arthritis Res. Ther. 8: 220–229). One
of the puzzling aspects of OA pain is the apparent disconnect between
disease severity and patient reported pain levels. Animal models of OA
provide a unique opportunity to investigate joint pain in an objective and
empirical manner.
Methods:We have examined nociception in two animal models of OA viz.
the Dunkin Hartley guinea pig model of spontaneous OA and the sodium
monoiodoacetate rat model of chemically-induced OA. In the guinea pig
model, the effect of age and joint destruction on joint nociceptor activity
was determined by comparing micro-CT and histomorphological markers
of knee joint pathology with single unit electrophysiological recordings
from articular primary afferents. Nerve recordings were also performed on
monoiodoacetate-induced OA rats as well as pain behaviour responses
using hindlimb weight bearing and von Frey hair algesiometry. Pharma-
cological interventions were carried out in the rat model to help identify
the chemical mediators involved in OA pain production and to discover
novel pain therapeutics.
Results: Both animal models demonstrated heightened nerve activity at
rest (spontaneous ﬁring) and in response to mechanical rotation of the
knee in the normal working range (non-noxious mechanical stimuli) and
during noxious hyper-rotation. Disease severity in Dunkin Hartley guinea
pig knees became progressively worse with advancing age and correlated
with increased body mass; however, OA severity did not correlate with
any of the objective electrophysiological measures of nociceptor activity.
Peripheral administration of the neuropeptide antagonist VIP6−28 to
monoiodoacetate-treated rat knees, reduced joint afferent sensitization
(Schuelert & McDougall, 2006. Osteoarthr. Cart. 14: 1155–1162) and
inhibited pain behaviour (McDougall et al., 2006. Pain 123: 98–105). In
other experiments, local administration of a cannabinoid agonist attenu-
ated afferent ﬁring rate indicative of an anti-nociceptive effect in OA joints
(Schuelert & McDougall, 2008. Arthritis Rheum. 58: 145–153).
Conclusions: These studies show that OA leads to peripheral sensitiza-
tion of knee joint sensory nerves and this heightened neural activity is the
physiological basis of joint pain. The data also provide the ﬁrst objective
evidence that disease severity is a poor indicator of joint pain. Moreover,
we have identiﬁed VIP6−28 and locally administered cannabinoids as
potential treatments for OA pain. Future studies using these and other OA
models are required to elucidate further the neurophysiological processes
responsible for generating joint pain so that novel therapeutics may be
developed allowing OA patients to lead a pain-free life.
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Purpose: Osteoarthritis (OA) is a major musculoskeletal disorder that
manifests with functional limitation and pain. In the United States, the
incidences of OA are projected to double by 2020 primarily due to in-
creased obesity. Although clinicians have concentrated upon treating the
symptoms of OA and, in some cases, by advising changes in diet, various
behavioral abnormalities may accompany the disease. This presentation
will describe some methods for examining abnormal behaviors in mouse
models of OA.
Methods: Neuromuscular status can be evaluated through behavioral
tests of reﬂexes, posture, grip-strength, pole-climbing/walking, gait, and
sensorimotor skills. Pain sensitivities are examined by tests of mechan-
ical and thermal sensitivities. Anxiety-like behaviors are analyzed by
responses in the zero maze, light-dark box, open ﬁeld, and novelty-
suppressed feeding tests, whereas depressive-like behaviors are studied
by forced swim, tail suspension, and anhedonia.
Results: In a genetic model of OA, Col9a1 mice showed knee joint
degeneration and were deﬁcient in sensorimotor responses and displayed
heightened mechanical sensitivities. In a diet-induced model of OA,
C57BL/6 mice fed a high fat diet also had knee joint changes. These
animals presented with some deﬁciencies in sensorimotor skills and they
displayed anxiety-like behaviors in the zero maze, as well as analgesia
in the hot plate but appeared normal in the tail ﬂick test.
Conclusions: As anticipated, these mouse models of OA show alter-
ations in sensorimotor responses and pain sensitivities. However, the
animals also display additional behavioral abnormalities. Clinicians should
be aware that OA patients may present with similar comorbidities and
treatment of these behaviors should be considered part of the regimen
for OA therapy.
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Purpose: To identify new osteoarthritis susceptibility genes for the onset
and progression of Osteoarthritis.
Methods: A genome-wide linkage scan and combined linkage asso-
ciation analysis was applied to 179 affected siblings and 4 trios with
generalized osteoarthritis (The GARP study). We tested for conﬁrmation
by association in 3 additional independent OA populations.
Results: Suggested evidence for linkage in the GARP study was ob-
served on chromosome 14q32.11 (LOD=3.03, P =1.9×10−4). Genotyp-
ing tagging SNPs covering three important candidate genes revealed
a common coding variant (rs225014; Thr92Ala) in the iodothyronine-
deiodinase enzyme type 2 (D2) gene (DIO2 [MIM 601413]) which
signiﬁcantly explained the linkage signal (P =0.006). Conﬁrmation and
replication by association in the additional osteoarthritis studies indi-
cated a common DIO2 haplotype, exclusively containing the minor al-
lele of rs225014 and common allele of rs12885300, with a combined
recessive odds ratio of 1.79, 95% conﬁdence interval [CI] 1.37−2.34
with P =2.02×10−5 in females cases with advanced/symptomatic hip
osteoarthritis. The gene product of this DIO2 converts intracellular pro-
hormone-3,3′,5,5′-tetraiodothyronine (T4) into the active thyroid hormone
